Aclaris Therapeutics (NASDAQ:ACRS) Coverage Initiated at Cantor Fitzgerald
Stock analysts at Cantor Fitzgerald initiated coverage on shares of Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) in a ...
Akebia Therapeutics Announces Pricing of Public Offering of Common Stock
Akebia Therapeutics®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of ...
BioSpace20h
Immunovant Will Drop One Myasthenia Gravis Asset, Continuing to Favor Another
Analysts were happy with batoclimab’s performance in the chronic autoimmune disorder, but Immunovant said it will continue to ...
Leerink says Sarepta stock reaction ‘overdone,’ remains positive on Elevidys
Leerink notes that shares of Outperform-rated Sarepta (SRPT) are under pressure on the heels of the disclosure of a patient death following ...
Fintel on MSN2d
Leerink Partners Initiates Coverage of Shattuck Labs (STTK) with Outperform Recommendation
Fintel reports that on March 17, 2025, Leerink Partners initiated coverage of Shattuck Labs (NasdaqGS:STTK) with a Outperform ...
Leerink says Incyte’s povo trial results disappoint, drug likely to be approved
Leerink analyst Andrew Berens notes that Outperform-rated Incyte (INCY) has reported the results of the two parallel Phase 3 trials evaluating ...
Fintel on MSN2d
Leerink Partners Initiates Coverage of Nurix Therapeutics (NRIX) with Market Perform Recommendation
Fintel reports that on March 17, 2025, Leerink Partners initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a ...